Abstract
Sympathomimetics and xanthines are widely used in the treatment of both acute and chronic asthma. They are generally believed to act primarily by reversing the contraction of airway smooth muscle, although they may have additional properties that may be beneficial in the treatment of asthma (Barnes, 1990). In this review, new developments and recent insights into the place of this 2 groups of drugs in the treatment of acute and chonic asthma will be presented. For a more in depth review, the reader is reffered to several recent reviews (Tattersfield 1988, Kerrebijn 1991, Svedmyr, 1988, Pauwels 1991, Persson 1991).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
